MRI
Diagnostic TestPelvis MRI
NCT Number: NCT02931721
Testes of men with non-obstructive azoospermia (NOA) are imaged using MRI to find potential differences depending on the outcome, ie. sperm recovery in consequent microdissection testicular sperm extraction (MD-TESE).
Looking for future studies?
Notify Me18 year–50 year
Male
Observational
Dept of Obst and Gyn, Turku, Finland
Sperm recovery rate in non-obstructive azoospermia (NOA) men is 43% in Turku University Hospital, depending on the diagnosis leading to NOA. To date, there are no known parameters known to differentiate between successful and unsuccessful sperm recovery.
MRI is performed on men prior to the operation, and the objective is to compare the functional parameters assessed by magnetic resonance imaging between the group of men with positive and the men with negative sperm recovery in testicular microdissection sperm extraction (MD-TESE).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pelvis MRI
Time frame: Baseline/ pre-invention
ADC differences by diagnosis and outcome
Turku University Hospital
Other Gov
Acronym: TESE-MRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02025270
Azoospermia, Genital Diseases
Cairo, Egypt
View Trial DetailsNCT05110391
Azoospermia, Endocrine System Diseases
Campinas, São Paulo, Brazil
View Trial DetailsNCT00548977
Azoospermia, Genital Diseases
Tainan, Taiwan
View Trial DetailsNCT05479474
Azoospermia, Azoospermia, Nonobstructive
Stanford, California, United States
View Trial Details